IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Galectin Therapeutics Inc

Q2 2016 vs Q3 2016

Comparing institutional holders between quarters

Quarters

Q3 2016Q2 2016Q1 2016Q4 2015Q3 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
UBS Group AG
UNCHANGED
Shares303 from 303
Change0 (0%)
Value$1 (+$1)
Filed 2016-11-14
Status
UBS Group AG
UNCHANGED30330300%$0$1+$12016-11-14
Showing 1 of 1 institutions